Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,737 Cr
up ₹167 Cr vs Jun 2025
- Stocks held
- 37
- up 1 vs Jun 2025
- Top 10 weight
- 56.5%
- of the portfolio in its ten largest
- Cash & debt
- 0.5%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 10, trimmed 10
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In July 2025 it disclosed 37 stocks worth ₹8,737 Cr, up ₹167 Cr from Jun 2025. Its largest positions were Sun Pharmaceutical Industries Limited (12.2%), Divi's Laboratories Limited (7.5%), Lupin Limited (5.9%); the ten largest together made up 56.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 75.5% of its equity. Cash and debt stood at 0.5%. Compared with Jun 2025 the fund entered 1 new stock and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
75%
Top-10 weight is higher than 75% of peers
Breadth
34%
Holds more stocks than 34% of peers
Cash
7%
Holds more cash than 7% of peers
Holdings in July 2025
Download CSVEvery line the fund disclosed, with the change against Jun 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 12.22%
- Δ weight
- down 0.01 pts
- Value
- ₹1,068 Cr
- Δ value
- up ₹19.4 Cr
- Status
- Added
- Weight
- 7.55%
- Δ weight
- down 0.95 pts
- Value
- ₹660 Cr
- Δ value
- down ₹69.1 Cr
- Status
- Trimmed
- Weight
- 5.93%
- Δ weight
- down 0.14 pts
- Value
- ₹518 Cr
- Δ value
- down ₹2.4 Cr
- Status
- Held
- Weight
- 5.69%
- Δ weight
- up 0.07 pts
- Value
- ₹497 Cr
- Δ value
- up ₹15.6 Cr
- Status
- Added
- Weight
- 5.69%
- Δ weight
- up 0.51 pts
- Value
- ₹497 Cr
- Δ value
- up ₹53.2 Cr
- Status
- Added
- Weight
- 5.57%
- Δ weight
- up 0.09 pts
- Value
- ₹486 Cr
- Δ value
- up ₹16.6 Cr
- Status
- Added
- Weight
- 3.86%
- Δ weight
- up 0.03 pts
- Value
- ₹338 Cr
- Δ value
- up ₹9.4 Cr
- Status
- Added
- Weight
- 3.55%
- Δ weight
- up 0.23 pts
- Value
- ₹310 Cr
- Δ value
- up ₹25.9 Cr
- Status
- Added
- Weight
- 3.31%
- Δ weight
- down 0.33 pts
- Value
- ₹289 Cr
- Δ value
- down ₹22.6 Cr
- Status
- Trimmed
- Weight
- 3.12%
- Δ weight
- down 0.15 pts
- Value
- ₹273 Cr
- Δ value
- down ₹7.8 Cr
- Status
- Trimmed
- Weight
- 3.02%
- Δ weight
- up 0.14 pts
- Value
- ₹264 Cr
- Δ value
- up ₹17 Cr
- Status
- Added
- Weight
- 2.70%
- Δ weight
- down 0.15 pts
- Value
- ₹236 Cr
- Δ value
- down ₹8.7 Cr
- Status
- Trimmed
- Weight
- 2.63%
- Δ weight
- up 0.59 pts
- Value
- ₹230 Cr
- Δ value
- up ₹55 Cr
- Status
- Added
- Weight
- 2.38%
- Δ weight
- up 0.06 pts
- Value
- ₹208 Cr
- Δ value
- up ₹9.4 Cr
- Status
- Added
- Weight
- 2.36%
- Δ weight
- up 0.06 pts
- Value
- ₹207 Cr
- Δ value
- up ₹8.9 Cr
- Status
- Added
- Weight
- 2.26%
- Δ weight
- down 1.29 pts
- Value
- ₹197 Cr
- Δ value
- down ₹107 Cr
- Status
- Trimmed
- Weight
- 2.23%
- Δ weight
- up 0.18 pts
- Value
- ₹194 Cr
- Δ value
- up ₹18.7 Cr
- Status
- Added
- Weight
- 2.22%
- Δ weight
- down 0.03 pts
- Value
- ₹194 Cr
- Δ value
- up ₹85 L
- Status
- Held
- Weight
- 2.22%
- Δ weight
- down 0.09 pts
- Value
- ₹194 Cr
- Δ value
- down ₹4 Cr
- Status
- Trimmed
- Weight
- 2.02%
- Δ weight
- up 0.07 pts
- Value
- ₹177 Cr
- Δ value
- up ₹9 Cr
- Status
- Added
- Weight
- 1.89%
- Δ weight
- down 0.22 pts
- Value
- ₹165 Cr
- Δ value
- down ₹15.4 Cr
- Status
- Trimmed
- Weight
- 1.86%
- Δ weight
- down <0.01 pts
- Value
- ₹163 Cr
- Δ value
- up ₹3 Cr
- Status
- Added
- Weight
- 1.77%
- Δ weight
- up 0.13 pts
- Value
- ₹155 Cr
- Δ value
- up ₹14.1 Cr
- Status
- Added
- Weight
- 1.54%
- Δ weight
- down 0.18 pts
- Value
- ₹134 Cr
- Δ value
- down ₹12.6 Cr
- Status
- Trimmed
- Weight
- 1.34%
- Δ weight
- up 0.10 pts
- Value
- ₹117 Cr
- Δ value
- up ₹11 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- up 0.05 pts
- Value
- ₹116 Cr
- Δ value
- up ₹6.6 Cr
- Status
- Added
- Weight
- 1.30%
- Δ weight
- up 0.09 pts
- Value
- ₹114 Cr
- Δ value
- up ₹10.1 Cr
- Status
- Added
- Weight
- 1.20%
- Δ weight
- down 0.22 pts
- Value
- ₹105 Cr
- Δ value
- down ₹16.8 Cr
- Status
- Trimmed
- Weight
- 1.08%
- Δ weight
- up 0.06 pts
- Value
- ₹94.7 Cr
- Δ value
- up ₹6.9 Cr
- Status
- Added
- Weight
- 1.05%
- Δ weight
- up 0.09 pts
- Value
- ₹91.4 Cr
- Δ value
- up ₹9.6 Cr
- Status
- Added
- Weight
- 0.92%
- Δ weight
- up 0.92 pts
- Value
- ₹80.4 Cr
- Δ value
- up ₹80.4 Cr
- Status
- New
- Weight
- 0.90%
- Δ weight
- up 0.25 pts
- Value
- ₹78.7 Cr
- Δ value
- up ₹23.3 Cr
- Status
- Added
- Weight
- 0.76%
- Δ weight
- up 0.05 pts
- Value
- ₹66.3 Cr
- Δ value
- up ₹5.4 Cr
- Status
- Added
- Weight
- 0.67%
- Δ weight
- down 0.01 pts
- Value
- ₹58.3 Cr
- Δ value
- up ₹5 L
- Status
- Held
- Weight
- 0.66%
- Δ weight
- up 0.01 pts
- Value
- ₹57.5 Cr
- Δ value
- up ₹1.7 Cr
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 0.55%
- Δ weight
- up 0.01 pts
- Value
- ₹47.9 Cr
- Δ value
- up ₹2.1 Cr
- Status
- Added
- Weight
- 0.42%
- Δ weight
- up 0.01 pts
- Value
- ₹36.5 Cr
- Δ value
- up ₹1.3 Cr
- Status
- Added
- Weight
- 0.23%
- Δ weight
- down 0.01 pts
- Value
- ₹19.7 Cr
- Δ value
- down ₹81 L
- Status
- Trimmed
What changed, Jun 2025 to Jul 2025
New New positions (1)
- Anthem Biosciences Limited0.9% · ₹80.4 Cr
Exited Exited (0)
None.
Added Biggest additions
- Thyrocare Technologies Limitedup ₹55 Cr (+0.59% pts)
- Dr. Reddy's Laboratories Limitedup ₹53.2 Cr (+0.51% pts)
- Vijaya Diagnostic Centre Limitedup ₹25.9 Cr (+0.23% pts)
- Akums Drugs and Pharmaceuticals Limitedup ₹23.3 Cr (+0.25% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Sector weights barely moved between Jun 2025 and Jul 2025.
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jul 2022 | Jul 2024 | Jan 2025 | Apr 2025 | Jun 2025 | Jul 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 80.4% | 79.2% | 77.0% | 76.4% | 75.4% | 75.5% |
| Healthcare Services | 17.4% | 17.4% | 19.2% | 19.6% | 20.0% | 20.0% |
| Retailing | — | 2.6% | 3.2% | 3.6% | 3.8% | 3.9% |
| Pharmaceuticals | 1.5% | 0.8% | 0.6% | 0.5% | 0.7% | 0.7% |
Allocation in Jul 2025change vs Jun 2025
- Pharmaceuticals & Biotechnology (27)75.5%
- Healthcare Services (8)20.0%▼ 0.1 pts
- Retailing (1)3.9%
- Pharmaceuticals (1)0.7%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Jul 2025
0.5%
unchanged vs Jun 2025
- Cash alone
- 0.6%
- cash and net receivables
- A year earlier
- 1.5%
- Jul 2024 · now ▼ 1.0 pts
- Last 12 months
- 0.3% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.